Skip to main content
Clinical Trials/ISRCTN71717097
ISRCTN71717097
Completed
未知

Bone-marrow derived stem cell transplantation in patients undergoing left ventricular restoration surgery for dilated ischaemic end-stage heart failure: a randomised blinded controlled trial

niversity Hospitals Bristol NHS Foundation Trust (UK)0 sites40 target enrollmentOctober 14, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Hospitals Bristol NHS Foundation Trust (UK)
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 14, 2009
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity Hospitals Bristol NHS Foundation Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Previous anterior myocardial infarction (with evidence of large surgically excludible scar at cardiac magnetic resonance imaging \[MRI])
  • 2\. Significant LV dilation (left ventricular end\-systolic volume index \[LVESVI] greater than or equal to 60 ml/m^2
  • 3\. Left ventricular ejection fraction less than or equal to 35%
  • 4\. New York Heart Association (NYHA) class III/IV and one episode of congestive heart failure (CHF) requiring medical attention
  • 5\. Elective left ventricular restoration surgery indicated
  • 6\. Elective CABG indicated to bypass stenoses or occlusions of coronary arteries
  • 7\. Patient aged 16 years or over and under 80 years old, either sex

Exclusion Criteria

  • 1\. Severe acute renal failure requiring dialysis or serum creatinine greater than or equal to 200 mmol/L
  • 2\. Atrial fibrillation
  • 3\. Malignancy
  • 4\. Debilitating neurological disease
  • 5\. Emergency operation for unstable angina
  • 6\. Previous cardiac surgery/sternotomy
  • 7\. Concomitant valve procedures
  • 8\. History of significant ventricular arrhythmias
  • 9\. History of pacemaker and/or defibrillator insertion
  • 10\. Right ventricular (RV) failure

Outcomes

Primary Outcomes

Not specified

Similar Trials